Transpek Industry (TRANSPEK) | Financial Analysis & Statements
Transpek Industry Ltd. Small-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
1.5B
Gross Profit
775.5M
50.28%
Operating Income
117.3M
7.60%
Net Income
155.8M
10.10%
EPS (Diluted)
₹27.90
Balance Sheet Metrics
Total Assets
10.0B
Total Liabilities
2.6B
Shareholders Equity
7.5B
Debt to Equity
0.34
Cash Flow Metrics
Revenue & Profitability Trend
Quarter Income Flow
Jun 30, 2025
Annual Income Flow
2025
Transpek Industry Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 6.5B | 5.8B | 8.3B | 6.0B | 3.4B |
| Cost of Goods Sold | 3.4B | 3.0B | 4.5B | 3.2B | 1.7B |
| Gross Profit | 3.1B | 2.8B | 3.8B | 2.8B | 1.7B |
| Gross Margin % | 47.1% | 48.6% | 45.8% | 46.2% | 50.1% |
| Operating Expenses | |||||
| Research & Development | 13.5M | 14.3M | 15.2M | 11.7M | 9.0M |
| Selling, General & Administrative | 623.7M | 539.4M | 736.7M | 494.1M | 239.6M |
| Other Operating Expenses | 716.7M | 820.3M | 851.4M | 720.4M | 518.8M |
| Total Operating Expenses | 1.4B | 1.4B | 1.6B | 1.2B | 767.4M |
| Operating Income | 619.9M | 517.4M | 1.3B | 768.4M | 258.9M |
| Operating Margin % | 9.6% | 8.9% | 15.9% | 12.8% | 7.6% |
| Non-Operating Items | |||||
| Interest Income | 52.1M | 33.8M | 16.1M | 15.8M | 6.1M |
| Interest Expense | 97.8M | 119.0M | 154.1M | 73.1M | 85.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | 616.6M | 555.1M | 1.1B | 842.4M | 255.4M |
| Income Tax | 129.2M | 169.5M | 293.2M | 188.4M | 22.3M |
| Effective Tax Rate % | 21.0% | 30.5% | 26.0% | 22.4% | 8.7% |
| Net Income | 487.4M | 385.6M | 834.8M | 654.0M | 233.1M |
| Net Margin % | 7.5% | 6.7% | 10.1% | 10.9% | 6.9% |
| Key Metrics | |||||
| EBITDA | 1.3B | 1.0B | 1.6B | 1.2B | 608.5M |
| EPS (Basic) | ₹87.25 | ₹69.03 | ₹149.45 | ₹117.09 | ₹41.74 |
| EPS (Diluted) | ₹87.25 | ₹69.03 | ₹149.45 | ₹117.09 | ₹41.74 |
| Basic Shares Outstanding | 5585569 | 5585569 | 5585569 | 5585569 | 5585569 |
| Diluted Shares Outstanding | 5585569 | 5585569 | 5585569 | 5585569 | 5585569 |
Income Statement Trend
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Transpek Industry Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 565.2M | 80.8M | 55.0M | 16.0M | 154.8M |
| Short-term Investments | 442.7M | 215.9M | 192.8M | 488.2M | 60.1M |
| Accounts Receivable | 1.0B | 918.6M | 1.2B | 991.8M | 761.2M |
| Inventory | 671.3M | 643.5M | 652.3M | 661.5M | 367.2M |
| Other Current Assets | 38.0K | 73.0K | 7.9M | 10.1M | 4.3M |
| Total Current Assets | 3.0B | 2.1B | 2.3B | 2.4B | 1.5B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 320.5M | 300.4M | 268.2M | 265.9M | 369.1M |
| Goodwill | 177.0K | 186.0K | 195.0K | 204.0K | 213.0K |
| Intangible Assets | 177.0K | 186.0K | 195.0K | 204.0K | 213.0K |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -6.0K | -7.0K | -10.0K | -11.0K | -105.0K |
| Total Non-Current Assets | 7.0B | 7.5B | 6.5B | 5.2B | 4.5B |
| Total Assets | 10.0B | 9.7B | 8.9B | 7.6B | 6.0B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 636.8M | 457.9M | 543.1M | 564.0M | 361.5M |
| Short-term Debt | 416.3M | 505.7M | 635.2M | 960.9M | 594.7M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 39.4M | 24.7M | - | 26.5M | 1.0K |
| Total Current Liabilities | 1.2B | 1.1B | 1.4B | 1.7B | 1.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 528.3M | 722.7M | 813.7M | 409.6M | 513.8M |
| Deferred Tax Liabilities | 773.0M | 1.0B | 799.7M | 698.3M | 584.8M |
| Other Non-Current Liabilities | - | - | 1.0K | 1.0K | 1.0K |
| Total Non-Current Liabilities | 1.3B | 1.8B | 1.6B | 1.1B | 1.1B |
| Total Liabilities | 2.6B | 2.9B | 3.0B | 2.8B | 2.2B |
| Equity | |||||
| Common Stock | 55.9M | 55.9M | 55.9M | 55.9M | 55.9M |
| Retained Earnings | 4.3B | 3.8B | 3.6B | 2.9B | 2.3B |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 7.5B | 6.7B | 5.9B | 4.8B | 3.8B |
| Key Metrics | |||||
| Total Debt | 944.5M | 1.2B | 1.4B | 1.4B | 1.1B |
| Working Capital | 1.8B | 1.0B | 987.9M | 783.0M | 472.7M |
Balance Sheet Composition
Transpek Industry Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 616.6M | 555.1M | 1.1B | 842.4M | 255.4M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 67.0M | 212.6M | -243.1M | -701.8M | -44.1M |
| Operating Cash Flow | 747.4M | 874.6M | 1.1B | 230.2M | 302.7M |
| Investing Activities | |||||
| Capital Expenditures | -189.4M | -380.4M | -445.5M | -379.1M | -144.2M |
| Acquisitions | 0 | 0 | 0 | 0 | 0 |
| Investment Purchases | - | - | - | -427.4M | -60.7M |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -187.2M | -382.6M | -446.6M | -806.0M | -204.3M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | -78.2M | -153.6M | -125.7M | -41.9M | -14.0M |
| Debt Issuance | 8.7M | - | - | 0 | 96.0M |
| Debt Repayment | -81.6M | -156.8M | -507.3M | -95.0M | -99.3M |
| Financing Cash Flow | -232.7M | -388.5M | -1.1B | 303.0M | 163.2M |
| Free Cash Flow | 1.1B | 581.6M | 615.2M | -5.9M | 169.8M |
| Net Change in Cash | 327.6M | 103.5M | -453.8M | -272.8M | 261.5M |
Cash Flow Trend
Transpek Industry Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
11.02
Forward P/E
15.27
Price to Book
0.84
Price to Sales
0.99
PEG Ratio
5.84
Profitability Ratios
Profit Margin
9.03%
Operating Margin
7.94%
Return on Equity
6.54%
Return on Assets
4.87%
Financial Health
Current Ratio
2.94
Debt to Equity
9.21
Beta
-0.12
Per Share Data
EPS (TTM)
₹104.37
Book Value per Share
₹1,374.42
Revenue per Share
₹1,156.73
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| TRANSPEK | 6.4B | 11.02 | 0.84 | 6.54% | 9.03% | 9.21 |
| Navin Fluorine | 322.4B | 57.84 | 8.89 | 10.99% | 17.74% | 32.68 |
| Deepak Nitrite | 230.5B | 43.19 | 4.18 | 12.85% | 6.71% | 22.41 |
| Ghcl | 46.2B | 9.54 | 1.33 | 17.89% | 16.60% | 2.66 |
| Styrenix Performance | 41.0B | 24.75 | 3.29 | 20.14% | 4.66% | 44.08 |
| Chemplast Sanmar | 38.6B | 210.40 | 2.02 | -5.34% | -7.01% | 96.73 |
Financial data is updated regularly. All figures are in the company's reporting currency.





